Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Alexandria Real Estate Equities (ARE)

Alexandria Real Estate Equities (ARE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 19,971,538
  • Shares Outstanding, K 122,600
  • Annual Sales, $ 1,327 M
  • Annual Income, $ 379,310 K
  • 60-Month Beta 0.70
  • Price/Sales 12.28
  • Price/Cash Flow 20.90
  • Price/Book 2.09

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 1.79
  • Number of Estimates 3
  • High Estimate 1.80
  • Low Estimate 1.78
  • Prior Year 1.68
  • Growth Rate Est. (year over year) +6.55%

Price Performance

See More
Period Period Low Period High Performance
1-Month
154.70 +5.30%
on 01/07/20
164.45 -0.94%
on 01/16/20
+8.00 (+5.16%)
since 12/17/19
3-Month
152.69 +6.69%
on 11/08/19
164.45 -0.94%
on 01/16/20
+7.59 (+4.89%)
since 10/17/19
52-Week
122.78 +32.68%
on 01/24/19
164.45 -0.94%
on 01/16/20
+40.15 (+32.71%)
since 01/17/19

Most Recent Stories

More News
Just - Evotec Biologics Announces Product Development And Manufacturing Agreement With Oncoresponse

JUST - EVOTEC BIOLOGICS WILL APPLY ITS FULLY INTEGRATED TECHNOLOGY PLATFORM IN ORDER TO ACCELERATE ONCORESPONSE'S LEAD PRODUCT CANDIDATE THROUGH DEVELOPMENT AND INTO THE CLINIC

ARE : 162.90 (-0.56%)
BMY : 66.72 (-0.09%)
NVS : 95.93 (+0.87%)
NVO : 61.31 (unch)
Alexandria LaunchLabs - AgTech, the Premier Platform Accelerating the Growth of Early--Stage AgTech and FoodTech Companies, to Award $100,000 AgTech Innovation Prize

Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first and longest-tenured owner, operator and developer uniquely focused on collaborative life science, technology and agtech...

ARE : 162.90 (-0.56%)
SmarTrend Watching for Potential Pullback in Shares of Alexandria Real After 1.12% Gain

Alexandria Real (NYSE:ARE) traded in a range yesterday that spanned from a low of $159.21 to a high of $159.96. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of...

ARE : 162.90 (-0.56%)
After Yesterday's Rally of 1.12% Shares Could Potentially Pullback

Alexandria Real (NYSE:ARE) traded in a range yesterday that spanned from a low of $159.21 to a high of $159.96. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of...

ARE : 162.90 (-0.56%)
Alexandria Real Estate Equities, Inc. Announces Closing Of Public Offering Of 6,900,000 Shares Of Common Stock, Including Exercise In Full Of Underwriters' Option To Purchase Additional Shares

Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) announced today the closing of its previously announced underwritten public offering of 6,900,000 shares of the Company's...

JPM : 138.20 (+0.69%)
WFC : 49.18 (-0.14%)
ARE : 162.90 (-0.56%)
Watch for Alexandria Real to Potentially Rebound After Falling 2.74% Yesterday

Alexandria Real (NYSE:ARE) traded in a range yesterday that spanned from a low of $156.30 to a high of $156.96. Yesterday, the shares fell 2.7%, which took the trading range below the 3-day low of $158.50...

ARE : 162.90 (-0.56%)
Alexandria Starts Underwriting of Public Offering of 6M Shares

Alexandria (ARE) intends to utilize capital raised from the public offering to fund its development projects and repay outstanding debt balances.

EGP : 135.58 (+0.51%)
DRE : 35.67 (+0.79%)
ARE : 162.90 (-0.56%)
BXP : 139.56 (+0.20%)
Alexandria Real Estate Equities, Inc. Announces Pricing Of Public Offering Of 6,000,000 Shares Of Common Stock

Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) announced today the pricing of its public offering of 6,000,000 shares of common stock at a price of $155.00 per share...

JPM : 138.20 (+0.69%)
WFC : 49.18 (-0.14%)
ARE : 162.90 (-0.56%)
Alexandria Real Estate Equities, Inc. Announces Public Offering Of 6,000,000 Shares Of Common Stock

Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) announced today that it is commencing an underwritten public offering of 6,000,000 shares of common stock, subject to market...

JPM : 138.20 (+0.69%)
ARE : 162.90 (-0.56%)
Boston Properties Announces 3% Sequential Hike in Dividend

Boston Properties' (BXP) latest quarterly dividend hike reflects its ability to generate solid cash flow through its operating platform.

AMT : 233.42 (+0.51%)
ADC : 72.54 (+0.22%)
BXP : 139.56 (+0.20%)
ARE : 162.90 (-0.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade ARE with:

Business Summary

Alexandria Real Estate Equities, Inc., Landlord and Developer of Choice to the Life Science Industry, is a publicly-traded real estate investment trust focused principally on the ownership, operation, management, selective redevelopment, development and acquisition of life science properties. Our properties...

See More

Key Turning Points

2nd Resistance Point 164.91
1st Resistance Point 163.91
Last Price 162.90
1st Support Level 162.35
2nd Support Level 161.79

See More

52-Week High 164.45
Last Price 162.90
Fibonacci 61.8% 148.53
Fibonacci 50% 143.61
Fibonacci 38.2% 138.70
52-Week Low 122.78

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar